
Last updated: 2026-09-07 18:43:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
CASI Pharmaceuticals, Inc. (CASI) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalization of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- |
CASI Pharmaceuticals, Inc. (CASI) last closed at $-- as of --, -- from the previous close of $--.
During the latest regular trading session, CASI traded between $-- and $--, with a volume of -- shares. The closing price was -- and --.
Over the past seven days, CASI Pharmaceuticals, Inc. (CASI) moved from $0.88 to $0.21, representing a decline of 76.31% ($0.67).
The stock traded between $0.21 and $0.89 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 1.45 million shares, up versus the previous seven-day period, indicating higher trading activity.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.
| Employees | 233 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of CASI Pharmaceuticals, Inc. (CASI) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.